封面
市場調查報告書
商品編碼
1433543

黴漿菌檢測市場規模、佔有率和趨勢分析:2024-2030 年按產品、技術、應用、最終用途、地區和細分市場進行的預測

Mycoplasma Testing Market Size, Share & Trends Analysis By Product (Instruments, Kits & Reagents), By Technology (PCR, ELISA, Direct Assay, Microbial Culture), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

黴漿菌檢測市場成長與趨勢:

根據Grand View Research, Inc.最新報告顯示,到2030年,全球黴漿菌檢測市場規模預計將達到22.6億美元,預測期內複合年成長率為13.58%。

推動市場擴張的主要因素包括生物製造、新興國家對黴漿菌檢測的需求增加以及藥品外包的擴大。此外,細胞株污染的增加、技術創新和生物科學研究也推動了整體市場的成長。

越來越多的政府舉措支持製藥和生技公司也推動了市場成長。美國FDA提案取消在體外活細胞培養中檢測黴漿菌的測試,並指出只有單一測試才能辨識支原體。生技藥品法規的這些變化預計將提高黴漿菌檢測測試的特異性和敏感性,並導致產業中新技術的引入。預計這將為新產品開發的主要參與者創造巨大的機會。

年終COVID-19 大流行期間,肺炎黴漿菌陽性率急劇下降。這是對 COVID-19 大流行採取嚴格監管的結果,成功阻止了肺炎支原體的傳播。然而,在放鬆COVID-19限制後,肺炎支原體預計將在整個研究期間進一步傳播,這將對黴漿菌檢測市場的成長產生積極影響。

增加研發投資對市場收益的擴張做出了重大貢獻。隨著醫療保健支出的增加,生命科學產業的研究活動顯著增加。藥物發現和開發新技術的採用以及細胞培養技術的創新正在推動黴漿菌檢測的需求。細胞培養物污染的高風險是預計在預測期內推動黴漿菌檢測市場的主要因素。

據估計,黴漿菌污染了全世界約 15% 至 35% 的連續細胞培養物。已知黴漿菌有 190 多種,但只有 8 種支原體造成了 95% 以上的細胞培養污染。不良的培養方法、氣溶膠、灰塵以及層流故障或破裂導致的交叉污染是導致細胞培養污染案例數量不斷增加的一些因素。這些因素預計將推動黴漿菌檢測解決方案的市場需求。

黴漿菌檢測市場報告亮點

  • 以產品來看,套件和試劑佔據市場主導地位,預計在整個預測期內將呈現最快的複合年成長率。
  • PCR 方法的主要優點是操作簡單且檢測快速。
  • 從應用來看,由於細胞培養領域所進行的研究計劃增加,細胞株檢測領域在2023年佔據最大佔有率,為41.65%。
  • 黴漿菌污染會引起細胞培養代謝物的變化並導致毒素的產生。因此,細胞株測試和認證在製藥和生物製藥行業變得越來越重要。
  • 北美地區佔比最大,2023年為39.04%。這主要是由於大量參與企業市場、研發成本增加以及聯邦援助。
  • 由於目標疾病盛行率上升以及隨著人口老化而提高的認知等因素,預計亞太地區將在預測期內實現最高的成長率。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場趨勢及展望
  • 市場動態
    • 生命科學領域研發投入增加
    • 政府加大對製藥和生技產業的支持
    • 細胞培養物污染增加
    • 對危及生命疾病的有效治療方法的需求不斷增加
    • 市場競爭加劇
  • 市場限制因素分析
    • 細胞生物學研究成本高昂
    • 黴漿菌生長緩慢
    • 假陰性結果的可能性
  • 營商環境分析
    • SWOT 分析;按因素(政治/法律、經濟/技術)
    • 波特五力分析
  • COVID-19感染疾病的影響分析

第4章 產品經營分析

  • 黴漿菌檢測市場:產品變異分析
  • 裝置
    • 2018-2030年設備市場
  • 套件和試劑
    • 套件和試劑市場,2018-2030
    • PCR檢測
    • 核酸檢測套件
    • 污垢
    • 拆卸套件
    • 標準和控制
    • 其他
  • 服務
    • 服務市場,2018-2030(百萬美元)

第5章技術業務分析

  • 黴漿菌檢測市場:技術變革分析
  • PCR
  • 酵素連結免疫吸附試驗
  • 直接測定
  • 間接測定
  • 微生物培養技術
  • 酵素法

第6章 應用業務分析

  • 黴漿菌檢測市場:應用變化分析
  • 細胞株測試
    • 細胞株測試市場,2018-2030
  • 病毒檢測
    • 病毒檢測市場,2018-2030
  • 測試壽命終止的細胞
    • 報廢電池檢測市場,2018-2030
  • 其他
    • 其他市場,2018-2030

第7章 最終用途業務分析

  • 黴漿菌測試市場:最終用途變異分析
  • 製藥和生物技術公司
  • 細胞庫
  • 合約研究組織
  • 學術研究所
  • 其他

第8章區域業務分析

  • 2023 年及 2030 年黴漿菌檢測市場佔有率佔有率(按地區)
  • 北美洲
    • SWOT分析
    • 北美黴漿菌檢測市場,2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • SWOT分析
    • 歐洲黴漿菌檢測市場,2018-2030
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
    • 俄羅斯
  • 亞太地區
    • SWOT分析
    • 亞太地區黴漿菌檢測市場,2018-2030
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
    • 新加坡
  • 拉丁美洲
    • SWOT分析
    • 拉丁美洲黴漿菌檢測市場,2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • SWOT分析
    • MEA黴漿菌檢測市場,2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭形勢

  • 公司分類
  • 策略規劃
    • 新產品發布
    • 合夥
    • 獲得
    • 合作
    • 資金籌措
  • 2023年主要企業市場佔有率分析
  • 公司簡介
    • Thermo Fisher Scientific, Inc.
    • Merck &Co., Inc.
    • Lonza Group AG
    • Charles River Laboratories International, Inc.
    • PromoCell GmbH
    • Asahi Kasei Medical Co., Ltd.
    • Sartorius AG
    • InvivoGen
    • Eurofins Scientific
    • (ATCC)American Type Culture Collection
Product Code: GVR-1-68038-897-8

Mycoplasma Testing Market Growth & Trends:

The global mycoplasma testing market size is expected to reach USD 2.26 billion by 2030, registering a CAGR of 13.58% over the forecast period, according to a new report by Grand View Research, Inc. The major factors driving the expansion of market includes growing demand for mycoplasma testing in biomanufacturing, emerging economies, and growing pharmaceutical outsourcing. Additionally, the market's overall growth is driven by rising cell-line contamination and innovation & research in biological sciences.

Growing number of government initiatives to support pharmaceutical and biotechnology companies is also driving the market growth. The U.S. FDA proposed to remove a test for detecting mycoplasma within in vitro living cell cultures, as it can help identify only a single test method. These changes in biologics regulations are anticipated to improve specificity and sensitivity in mycoplasma detection tests, leading to introduction of new technologies in the industry. This is expected to create immense opportunities for key players in new product development.

The rates of M. pneumoniae positivity sharply decreased during the COVID-19 pandemic outbreak at the end of 2019. This was a result of the COVID-19 pandemic's stringent regulations, which successfully stopped the spread of M. pneumonia. However, it is anticipated that M. pneumonia will expand even more throughout the research period following the relaxation of COVID-19 limits, which will have a positive impact on the mycoplasma testing market's growth.

Increasing investments in R&D have contributed significantly to the market's revenue growth. With rising healthcare expenditure, research activities in the life sciences industry are increasing significantly. The adoption of new technologies for drug discovery & development and innovations in cell culture technologies are driving the demand for mycoplasma tests. The high risk of cell culture contamination remains the primary factor expected to drive the mycoplasma testing market over the forecast period

Mycoplasma is estimated to contaminate around 15%-35% of all continuous cell cultures around the world. Out of over 190 known species of mycoplasma, only eight species are responsible for more than 95% of cell culture contamination. Poor cultural practices, aerosols, dust, and cross-contamination as a result of faulty or broken laminar flow are some of the factors responsible for an increase in the number of cell culture contamination events. Such factors are likely to drive the market demand for mycoplasma testing solutions.

Mycoplasma Testing Market Report Highlights:

  • By product, kits and reagents dominated the market, and are anticipated to exhibit the fastest CAGR throughout the forecast period, due to their widespread use in mycoplasma testing
  • Ease of conducting the procedure and rapid detection are some of the major advantages offered by the PCR method
  • By application, the cell line testing segment held a largest share of 41.65% in 2023, owing to the increase in research projects being done in the field of cell culture
  • Mycoplasma contamination can cause alterations in cell culture metabolites and lead to development of toxins. This increases the importance of cell line testing and authentication in the pharmaceutical and biopharmaceutical industries
  • North America held the largest share of 39.04% in 2023. This is mostly attributed to the presence of significant market participants, as well as rising R&D spending and federal assistance
  • In Asia Pacific, the market is expected to grow at the highest rate in a projected time period driven by factors such as the rising prevalence of target diseases with an aging population, rising awareness and others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Test Segment
      • 1.1.1.2 Service Provider Segment
      • 1.1.1.3 Application Segment
  • 1.2 Regional Scope
  • 1.3 Estimates and Forecasts Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 List of Secondary Sources
  • 1.11 List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increasing R&D investments in life sciences
    • 3.4.2. Rising government support toward pharmaceutical and biotechnology industries
    • 3.4.3. Rising cell culture contamination
    • 3.4.4. Growing demand for the introduction of effective treatment of life-threatening diseases
    • 3.4.5. Increased competition in the market
  • 3.5. Market Restraint Analysis
    • 3.5.1. High cost of research in cell biology
    • 3.5.2. Slow rate of mycoplasma growth
    • 3.5.3. Possibility of false negative results
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
  • 3.7. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Mycoplasma Testing Market: Product Movement Analysis
  • 4.2. Instruments
    • 4.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.3. Kits & Reagents
    • 4.3.1. Kits & Reagents Market, 2018 - 2030 (USD Million)
    • 4.3.2. PCR Assays
      • 4.3.2.1. PCR Assays Market, 2018 - 2030 (USD Million)
    • 4.3.3. Nucleic Acid Detection Kits
      • 4.3.3.1. Nucleic Acid Detection Kits Market, 2018 - 2030 (USD Million)
    • 4.3.4. Stains
      • 4.3.4.1. Stains Market, 2018 - 2030 (USD Million)
    • 4.3.5. Elimination Kits
      • 4.3.5.1. Elimination Kits Market, 2018 - 2030 (USD Million)
    • 4.3.6. Standards & Controls
      • 4.3.6.1. Standards & Controls Market, 2018 - 2030 (USD Million)
    • 4.3.7. Others
      • 4.3.7.1. Others Market, 2018 - 2030 (USD Million)
  • 4.4. Services
    • 4.4.1. Services Market, 2018 - 2030 (USD Million

Chapter 5. Technology Business Analysis

  • 5.1. Mycoplasma Testing Market: Technology Movement Analysis
  • 5.2. PCR
    • 5.2.1. PCR Market, 2018 - 2030 (USD Million)
  • 5.3. ELISA
    • 5.3.1. ELISA Market, 2018 - 2030 (USD Million)
  • 5.4. Direct Assay
    • 5.4.1. Direct Assay Market, 2018 - 2030 (USD Million)
  • 5.5. Indirect Assay
    • 5.5.1. Indirect Assay Market, 2018 - 2030 (USD Million)
  • 5.6. Microbial Culture Techniques
    • 5.6.1. Microbial Culture Techniques Market, 2018 - 2030 (USD Million)
  • 5.7. Enzymatic Methods
    • 5.7.1. Enzymatic Methods Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Mycoplasma Testing Market: Application Movement Analysis
  • 6.2. Cell Line Testing
    • 6.2.1. Cell Line Testing Market, 2018 - 2030 (USD Million)
  • 6.3. Virus Testing
    • 6.3.1. Virus Testing Market, 2018 - 2030 (USD Million)
  • 6.4. End of Production Cells Testing
    • 6.4.1. End of Production Cells Testing Market, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. End-use Business Analysis

  • 7.1. Mycoplasma Testing Market: End-use Movement Analysis
  • 7.2. Pharmaceutical & Biotechnology Companies
    • 7.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 7.3. Cell Banks
    • 7.3.1. Cell Banks Market, 2018 - 2030 (USD Million)
  • 7.4. Contract Research Organizations
    • 7.4.1. Contract Research Organizations Market, 2018 - 2030 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Mycoplasma Testing Market Share By Region, 2023 & 2030
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Target Disease Prevalence
      • 8.2.3.3. Competitive Scenario
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. Reimbursement Scenario
      • 8.2.3.6. U.S. Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.2.4. Canada
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Target Disease Prevalence
      • 8.2.4.3. Competitive Scenario
      • 8.2.4.4. Regulatory Framework
      • 8.2.4.5. Reimbursement Scenario
      • 8.2.4.6. Canada Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. SWOT Analysis
    • 8.3.2. Europe Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Target Disease Prevalence
      • 8.3.3.3. Competitive Scenario
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Reimbursement Scenario
      • 8.3.3.6. Germany Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.4. UK
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Target Disease Prevalence
      • 8.3.4.3. Competitive Scenario
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. Reimbursement Scenario
      • 8.3.4.6. UK Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.5. France
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Target Disease Prevalence
      • 8.3.5.3. Competitive Scenario
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Reimbursement Scenario
      • 8.3.5.6. France Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.6. Italy
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Target Disease Prevalence
      • 8.3.6.3. Competitive Scenario
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Reimbursement Scenario
      • 8.3.6.6. Italy Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.7. Spain
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Target Disease Prevalence
      • 8.3.7.3. Competitive Scenario
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Reimbursement Scenario
      • 8.3.7.6. Spain Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.8. Denmark
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Target Disease Prevalence
      • 8.3.8.3. Competitive Scenario
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Reimbursement Scenario
      • 8.3.8.6. Denmark Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.9. Sweden
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Target Disease Prevalence
      • 8.3.9.3. Competitive Scenario
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Reimbursement Scenario
      • 8.3.9.6. Sweden Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.10. Norway
      • 8.3.10.1. Key Country Dynamics
      • 8.3.10.2. Target Disease Prevalence
      • 8.3.10.3. Competitive Scenario
      • 8.3.10.4. Regulatory Framework
      • 8.3.10.5. Reimbursement Scenario
      • 8.3.10.6. Norway Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.3.11. Russia
      • 8.3.11.1. Key Country Dynamics
      • 8.3.11.2. Target Disease Prevalence
      • 8.3.11.3. Competitive Scenario
      • 8.3.11.4. Regulatory Framework
      • 8.3.11.5. Reimbursement Scenario
      • 8.3.11.6. Russia Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. SWOT Analysis
    • 8.4.2. Asia Pacific Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Target Disease Prevalence
      • 8.4.3.3. Competitive Scenario
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. Reimbursement Scenario
      • 8.4.3.6. Japan Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.4.4. China
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Target Disease Prevalence
      • 8.4.4.3. Competitive Scenario
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. Reimbursement Scenario
      • 8.4.4.6. China Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.4.5. India
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Target Disease Prevalence
      • 8.4.5.3. Competitive Scenario
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Reimbursement Scenario
      • 8.4.5.6. India Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Target Disease Prevalence
      • 8.4.6.3. Competitive Scenario
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Reimbursement Scenario
      • 8.4.6.6. South Korea Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.4.7. Australia
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Target Disease Prevalence
      • 8.4.7.3. Competitive Scenario
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. Reimbursement Scenario
      • 8.4.7.6. Australia Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.4.8. Thailand
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Target Disease Prevalence
      • 8.4.8.3. Competitive Scenario
      • 8.4.8.4. Regulatory Framework
      • 8.4.8.5. Reimbursement Scenario
      • 8.4.8.6. Thailand Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.4.9. Singapore
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Target Disease Prevalence
      • 8.4.9.3. Competitive Scenario
      • 8.4.9.4. Regulatory Framework
      • 8.4.9.5. Reimbursement Scenario
      • 8.4.9.6. Singapore Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. SWOT Analysis
    • 8.5.2. Latin America Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Target Disease Prevalence
      • 8.5.3.3. Competitive Scenario
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Reimbursement Scenario
      • 8.5.3.6. Brazil Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.5.4. Mexico
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Target Disease Prevalence
      • 8.5.4.3. Competitive Scenario
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Reimbursement Scenario
      • 8.5.4.6. Mexico Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.5.5. Argentina
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Target Disease Prevalence
      • 8.5.5.3. Competitive Scenario
      • 8.5.5.4. Regulatory Framework
      • 8.5.5.5. Reimbursement Scenario
      • 8.5.5.6. Argentina Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. SWOT Analysis
    • 8.6.2. MEA Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.6.3. South Africa
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Target Disease Prevalence
      • 8.6.3.3. Competitive Scenario
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Reimbursement Scenario
      • 8.6.3.6. South Africa Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.6.4. Saudi Arabia
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Target Disease Prevalence
      • 8.6.4.3. Competitive Scenario
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. Reimbursement Scenario
      • 8.6.4.6. Saudi Arabia Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.6.5. UAE
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Target Disease Prevalence
      • 8.6.5.3. Competitive Scenario
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Reimbursement Scenario
      • 8.6.5.6. UAE Mycoplasma Testing Market, 2018 - 2030 (USD Million)
    • 8.6.6. Kuwait
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Target Disease Prevalence
      • 8.6.6.3. Competitive Scenario
      • 8.6.6.4. Regulatory Framework
      • 8.6.6.5. Reimbursement Scenario
      • 8.6.6.6. Kuwait Mycoplasma Testing Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1 Company Categorization
  • 9.2 Strategy Mapping
    • 9.2.1 New Product Launch
    • 9.2.2 Partnerships
    • 9.2.3 Acquision
    • 9.2.4 Collaboration
    • 9.2.5 Funding
  • 9.3 Key Company Market Share Analysis, 2023
  • 9.4 Company Profiles
    • 9.4.1 Thermo Fisher Scientific, Inc.
      • 9.4.1.1 Company overview
      • 9.4.1.2 Financial performance
      • 9.4.1.3 Product benchmarking
      • 9.4.1.4 Strategic Initiatives
    • 9.4.2 Merck & Co., Inc.
      • 9.4.2.1 Company overview
      • 9.4.2.2 Financial performance
      • 9.4.2.3 Product benchmarking
      • 9.4.2.4 Strategic Initiatives
    • 9.4.3 Lonza Group AG
      • 9.4.3.1 Company overview
      • 9.4.3.2 Financial performance
      • 9.4.3.3 Product benchmarking
      • 9.4.3.4 Strategic Initiatives
    • 9.4.4 Charles River Laboratories International, Inc.
      • 9.4.4.1 Company overview
      • 9.4.4.2 Product benchmarking
      • 9.4.4.3 Strategic Initiatives
    • 9.4.5 PromoCell GmbH
      • 9.4.5.1 Company overview
      • 9.4.5.2 Financial performance
      • 9.4.5.3 Product benchmarking
      • 9.4.5.4 Strategic Initiatives
    • 9.4.6 Asahi Kasei Medical Co., Ltd.
      • 9.4.6.1 Company overview
      • 9.4.6.2 Financial performance
      • 9.4.6.3 Product benchmarking
      • 9.4.6.4 Strategic Initiatives
    • 9.4.7 Sartorius AG
      • 9.4.7.1 Company overview
      • 9.4.7.2 Financial performance
      • 9.4.7.3 Product benchmarking
      • 9.4.7.4 Strategic Initiatives
    • 9.4.8 InvivoGen
      • 9.4.8.1 Company overview
      • 9.4.8.2 Financial performance
      • 9.4.8.3 Product benchmarking
      • 9.4.8.4 Strategic Initiatives
    • 9.4.9 Eurofins Scientific
      • 9.4.9.1 Company overview
      • 9.4.9.2 Financial performance
      • 9.4.9.3 Product benchmarking
      • 9.4.9.4 Strategic Initiatives
    • 9.4.10 (ATCC) American Type Culture Collection
      • 9.4.10.1 Company overview
      • 9.4.10.2 Financial performance
      • 9.4.10.3 Product benchmarking
      • 9.4.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Mycoplasma Testing Market, by Region, 2018 - 2030 (USD Million)
  • Table 4 Global Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 5 Global Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 7 Global Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 8 North America Mycoplasma Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 10 North America Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 11 North America Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 12 North America Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 13 U.S. Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 14 U.S. Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 15 U.S. Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 17 Canada Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 Canada Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 Canada Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 20 Canada Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 21 Europe Mycoplasma Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Europe Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Europe Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 25 Europe Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 26 Germany Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 27 Germany Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 28 Germany Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 29 Germany Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 30 UK Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 31 UK Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 32 UK Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 33 UK Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 34 France Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 France Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 36 France Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 France Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 38 Italy Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 Italy Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 Italy Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Italy Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 42 Spain Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 43 Spain Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 44 Spain Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 45 Spain Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 46 Denmark Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 47 Denmark Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 48 Denmark Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 49 Denmark Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 50 Sweden Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 51 Sweden Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 52 Sweden Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 53 Sweden Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 54 Norway Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 55 Norway Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 56 Norway Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 Norway Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 58 Russia Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 59 Russia Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 60 Russia Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 61 Russia Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Mycoplasma Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 67 China Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 68 China Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 China Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 70 China Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 71 Japan Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 72 Japan Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 73 Japan Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 74 Japan Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 75 India Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 76 India Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 77 India Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 78 India Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 79 South Korea Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 80 South Korea Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 South Korea Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 82 South Korea Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 83 Australia Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 84 Australia Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 85 Australia Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 86 Australia Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 87 Thailand Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 88 Thailand Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 89 Thailand Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 90 Thailand Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 91 Singapore Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 92 Singapore Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 93 Singapore Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 94 Singapore Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 95 Latin America Mycoplasma Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 96 Latin America Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 97 Latin America Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 98 Latin America Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 99 Latin America Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 100 Brazil Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 101 Brazil Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 102 Brazil Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 103 Brazil Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 104 Mexico Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 105 Mexico Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 106 Mexico Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 107 Mexico Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 108 Argentina Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 109 Argentina Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 110 Argentina Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 111 Argentina Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 112 Middle East & Africa Mycoplasma Testing Market, by Country, 2018 - 2030 (USD Million)
  • Table 113 Middle East & Africa Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 114 Middle East & Africa Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 115 Middle East & Africa Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 116 Middle East & Africa Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 117 South Africa Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 118 South Africa Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 119 South Africa Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 120 South Africa Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 121 Saudi Arabia Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 122 Saudi Arabia Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 123 Saudi Arabia Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 124 Saudi Arabia Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 125 UAE Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 126 UAE Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 127 UAE Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 128 UAE Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)
  • Table 129 Kuwait Mycoplasma Testing Market, by Product, 2018 - 2030 (USD Million)
  • Table 130 Kuwait Mycoplasma Testing Market, by Application, 2018 - 2030 (USD Million)
  • Table 131 Kuwait Mycoplasma Testing Market, by Technology, 2018 - 2030 (USD Million)
  • Table 132 Kuwait Mycoplasma Testing Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Mycoplasma Testing Market Segmentation
  • Fig. 8 Market Snapshot, 2023
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Mycoplasma Testing Market: by Product Movement Analysis
  • Fig. 16 Global Mycoplasma Testing Market, for Instruments, 2018 - 2030 (USD Million)
  • Fig. 17 Global Mycoplasma Testing Market, for Kits & Reagents, 2018 - 2030 (USD Million)
  • Fig. 18 Global Mycoplasma Testing Market, for PCR Assays, 2018 - 2030 (USD Million)
  • Fig. 19 Global Mycoplasma Testing Market, for Nucleic Acid Detection Kits, 2018 - 2030 (USD Million)
  • Fig. 20 Global Mycoplasma Testing Market, for Stains, 2018 - 2030 (USD Million)
  • Fig. 21 Global Mycoplasma Testing Market, for Elimination Kits, 2018 - 2030 (USD Million)
  • Fig. 22 Global Mycoplasma Testing Market, for Standards & Controls, 2018 - 2030 (USD Million)
  • Fig. 23 Global Mycoplasma Testing Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 24 Global Mycoplasma Testing Market, for Services, 2018 - 2030 (USD Million)
  • Fig. 25 Global Mycoplasma Testing Market: Technology Movement Analysis
  • Fig. 26 Global Mycoplasma Testing Market, for PCR, 2018 - 2030 (USD Million)
  • Fig. 27 Global Mycoplasma Testing Market, for ELISA, 2018 - 2030 (USD Million)
  • Fig. 28 Global Mycoplasma Testing Market, for Direct Assay, 2018 - 2030 (USD Million)
  • Fig. 29 Global Mycoplasma Testing Market, for Indirect Assay, 2018 - 2030 (USD Million)
  • Fig. 30 Global Mycoplasma Testing Market, for Microbial Culture Techniques, 2018 - 2030 (USD Million)
  • Fig. 31 Global Mycoplasma Testing Market, for Enzymatic Methods, 2018 - 2030 (USD Million)
  • Fig. 32 Global Mycoplasma Testing Market: Application Movement Analysis
  • Fig. 33 Global Mycoplasma Testing Market, for Cell Line Testing, 2018 - 2030 (USD Million)
  • Fig. 34 Global Mycoplasma Testing Market, for Virus Testing, 2018 - 2030 (USD Million)
  • Fig. 35 Global Mycoplasma Testing Market, for End of Production Cells Testing, 2018 - 2030 (USD Million)
  • Fig. 36 Global Mycoplasma Testing Market, for Other Applications, 2018 - 2030 (USD Million)
  • Fig. 37 Global Mycoplasma Testing Market: End-use Movement Analysis
  • Fig. 38 Global Mycoplasma Testing Market, for Pharmaceutical & Biotechnology Companies, 2018 - 2030 (USD Million)
  • Fig. 39 Global Mycoplasma Testing Market, for Cell Banks, 2018 - 2030 (USD Million)
  • Fig. 40 Global Mycoplasma Testing Market, for Contract Research Organizations, 2018 - 2030 (USD Million)
  • Fig. 41 Global Mycoplasma Testing Market, for Academic & Research Institutes,
  • Fig. 42 Global Mycoplasma Testing Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 43 Regional Marketplace: Key Takeaways Mycoplasma Testing Market, Region 2018 - 2030 (USD Million)
  • Fig. 44 Mycoplasma Testing Market :Regional Outlook, 2023 & 2030, 2018 - 2030 (USD Million)
  • Fig. 45 North America Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 46 U.S. Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 47 Canada Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 48 Europe Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 49 Germany Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 50 UK Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 51 France Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 52 Italy Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 53 Spain Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 56 Norway Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 57 Russia Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 59 Japan Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 60 China Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 61 India Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 62 Australia Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 63 South Korea Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 65 Singapore Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 68 Mexico Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 70 Middle East and Africa Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 72 Saudi Arabia Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 73 UAE Mycoplasma Testing Market, 2018 - 2030 (USD Million)
  • Fig. 74 Kuwait Mycoplasma Testing Market, 2018 - 2030 (USD Million)